| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 7.14 Billion | USD 15.99 Billion | 8.40% | 2024 |
FrequentlyAsked Questions
Veterinary contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) are specialized agencies helping pharmaceutical and biotechnology companies develop and manufacture new drugs for veterinary care.
The global veterinary CRO and CDMO market is expected to be influenced by the increasing number of pet owners worldwide.
According to study, the global veterinary CRO & CDMO market size was worth around USD 7.14 billion in 2024 and is predicted to grow to around USD 15.99 billion by 2034.
The CAGR value of the veterinary CRO & CDMO market is expected to be around 8.40% during 2025-2034.
The global veterinary CRO & CDMO market will be led by North America during the projection period.
The global veterinary CRO & CDMO market is led by players like Oncovet Clinical Research (OCR), Charles River Laboratories, Veterinary Research Management, Charles River Laboratories, Oncovet Clinical Research (OCR), IDEXX Laboratories Inc., TriRx Pharmaceutical Services, Zoetis Nexvet, LABIANA Group, Knoell Triveritas, Vetio, AB7 Group, Argenta Group (KLIFOVET GmbH), Inotiv, Aenova Group, VETSPIN, and Clinvet.
The report explores crucial aspects of the veterinary CRO & CDMO market, including a detailed discussion of existing growth factors and restraints, while browsing future growth opportunities and challenges that impact the market.
HappyClients